Defender Capital LLC. Acquires Shares of 41,845 Axon Enterprise, Inc $AXON

Defender Capital LLC. bought a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 41,845 shares of the biotechnology company’s stock, valued at approximately $23,765,000. Axon Enterprise comprises about 7.7% of Defender Capital LLC.’s investment portfolio, making the stock its 4th biggest holding. Defender Capital LLC. owned approximately 0.05% of Axon Enterprise at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in AXON. NEOS Investment Management LLC lifted its stake in Axon Enterprise by 82.7% in the third quarter. NEOS Investment Management LLC now owns 25,369 shares of the biotechnology company’s stock valued at $18,206,000 after purchasing an additional 11,482 shares during the last quarter. Vanguard Group Inc. increased its position in Axon Enterprise by 4.2% in the third quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after buying an additional 376,904 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its position in Axon Enterprise by 3.3% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 184,423 shares of the biotechnology company’s stock worth $132,349,000 after buying an additional 5,953 shares during the last quarter. BIT Capital GmbH raised its stake in shares of Axon Enterprise by 75.6% in the third quarter. BIT Capital GmbH now owns 3,535 shares of the biotechnology company’s stock valued at $2,537,000 after buying an additional 1,522 shares during the period. Finally, Legal & General Group Plc raised its stake in shares of Axon Enterprise by 3.1% in the third quarter. Legal & General Group Plc now owns 421,114 shares of the biotechnology company’s stock valued at $302,208,000 after buying an additional 12,736 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Northcoast Research upgraded Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price target for the company in a research note on Tuesday, January 6th. Craig Hallum restated a “buy” rating and issued a $820.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 25th. UBS Group dropped their price objective on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating on the stock in a report on Wednesday, February 25th. Robert W. Baird set a $800.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 25th. Finally, Morgan Stanley reduced their target price on shares of Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Sixteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $762.93.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $460.15 on Thursday. Axon Enterprise, Inc has a 52-week low of $396.41 and a 52-week high of $885.91. The stock has a fifty day moving average of $509.91 and a 200 day moving average of $595.01. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53. The firm has a market capitalization of $37.00 billion, a price-to-earnings ratio of 302.73, a P/E/G ratio of 9.75 and a beta of 1.46.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.55. The business had revenue of $796.72 million for the quarter, compared to analyst estimates of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The company’s quarterly revenue was up 38.5% compared to the same quarter last year. During the same period in the prior year, the company earned $2.08 EPS. On average, research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $535.01, for a total value of $1,070,020.00. Following the sale, the insider directly owned 55,588 shares of the company’s stock, valued at $29,740,135.88. This trade represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Jennifer H. Mak sold 1,500 shares of Axon Enterprise stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $573.45, for a total transaction of $860,175.00. Following the sale, the chief accounting officer owned 12,240 shares of the company’s stock, valued at approximately $7,019,028. The trade was a 10.92% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 23,855 shares of company stock valued at $13,299,928 in the last 90 days. 4.40% of the stock is owned by company insiders.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon’s AI products (DraftOne, Fusus, Drone as First Responder) are producing very large bookings and attracting both public-safety and defense interest, suggesting meaningful revenue upside and new contract opportunities. Is Axon (AXON) Quietly Shifting Its AI Defense Ambitions As Board Veteran Julie Cullivan Exits?
• Positive Sentiment: Axon reported 36% EBITDA growth and margin expansion, showing operating leverage as revenues scale — a core positive for valuation if management can sustain margins. Can Axon Sustain EBITDA Margin Momentum Amid Cost Pressures?
• Positive Sentiment: Commentary linking Axon to a proposed large U.S. defense spending push has framed Axon as a top-rated defense/security name, which could drive re-rating if defense budgets translate into larger bookings. Hegseth Says It ‘Takes Money to Kill Bad Guys’ Amid $200 Billion Spending Push. Why Axon and L3Harris Are the 2 Top-Rated Defense Stocks to Buy Now
• Positive Sentiment: Short-term price momentum: recent write-ups note Axon has outpaced the market in recent sessions, reinforcing bullish investor sentiment. Axon Enterprise (AXON) Surpasses Market Returns: Some Facts Worth Knowing
• Neutral Sentiment: Short-interest reports this month show anomalous “0 shares” and 0.0 days-to-cover figures across feeds — data appears unreliable and should not be treated as a clear signal until corrected. (Multiple market-data postings)
• Negative Sentiment: Peer comparison: Teledyne (TDY) is cited as having stronger near-term defense demand and a more attractive valuation, implying Axon may face tougher relative upside if investors rotate to better-valued defense names. Axon vs. Teledyne: Which Defense & Security Stock has Greater Upside?
• Negative Sentiment: Valuation risk: broader coverage warns that high-growth, premium-valued stocks like Axon have limited margin for execution misses — rising costs noted by analysts could test expectations and amplify downside on any miss. 2 High-Flying Stocks to Keep an Eye On and 1 Facing Headwinds

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.